Summary: This ADC product is comprised of an anti-CD70 monoclonal antibody (clone c1F6) conjugated via a VC linker to a AFP. The AFP is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, AFP binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-cd70-14.htm